Epigenetic Control of MAGE Gene Expression by the KIT Tyrosine Kinase
- 1 September 2007
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 127 (9), 2123-2128
- https://doi.org/10.1038/sj.jid.5700836
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Promoter methylation profiling of 30 genes in human malignant melanomaCancer Science, 2004
- Immunohistochemical Profiling of Germ Cells Within the Human Fetal Testis: Identification of Three SubpopulationsBiology of Reproduction, 2004
- Limited Gene Activation in Tumor and Normal Epithelial Cells Treated with the DNA Methyltransferase Inhibitor 5-Aza-2′-deoxycytidinePublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Cytolytic T‐cell responses of cancer patients vaccinated with a MAGE antigenImmunological Reviews, 2002
- CT7 (MAGE‐C1) antigen expression in normal and neoplastic tissuesInternational Journal of Cancer, 2002
- Expression of MAGE-antigens in normal tissues and cancerInternational Journal of Cancer, 2000
- Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertilityNature Genetics, 2000
- DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich PromoterMolecular and Cellular Biology, 1999
- Deficiency of Trp53 Rescues the Male Fertility Defects of KitW-v Mice but Has No Effect on the Survival of Melanocytes and Mast CellsDevelopmental Biology, 1999
- Decreased expression of the c-kit receptor is associated with increased apoptosis in subfertile human testesFertility and Sterility, 1999